About Baysil Pharma Private Limited
Data last updated:
Baysil Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 13 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2007PTC169939.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors Ketan Hiren Desai and Manasvvi Naishadh Desai.
Its last annual general meeting (AGM) was held on 28 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 18 'F' Block Road MIDC Marol Andheri (East), Mumbai, Maharashtra, India – 400093.
The company has 1 deal on record (1 secondary share transfer); the latest was in September 2012.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website basilpharmaceutical.com.
Company details
Contact details
Baysil Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is basilpharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 18 'F' Block Road MIDC Marol Andheri (East), Mumbai, Maharashtra, India – 400093
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Baysil Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Baysil Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Baysil Pharma Private Limited, buy the company report.
Board of directors of Baysil Pharma Private Limited
Baysil Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ketan Hiren Desai Also directs: Baysil Chemicals Private Limited, Baysil Polymers Private Limited, Britacel Silicones Limited and 1 more | Director | 13 Apr 2007 | 19 Years 6 Months | Current |
| Manasvvi Naishadh Desai | Director | 09 Jan 2018 | 8 Years 9 Months | Current |
Auditor
Baysil Pharma Private Limited is audited by Y. K. Desai & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y. K. Desai & Co. | FY 2023 | 102370W |
Shareholding
The shareholding of Baysil Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Baysil Pharma Private Limited, buy the company report.
Deals & funding
Baysil Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in September 2012.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Britacel Silicones Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Baysil Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Baysil Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Baysil Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Baysil Pharma Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Nalini Hiren Vashi ceased to be Director on 08 Nov 2018.
Frequently asked questions
Baysil Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 13 April 2007 (19+ years old) and is registered under CIN U24100MH2007PTC169939.
Baysil Pharma has 2 current directors:
- Ketan Hiren Desai - Director
- Manasvvi Naishadh Desai - Director
The latest financial statements of Baysil Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 July 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Baysil Pharma is U24100MH2007PTC169939. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baysil Pharma was incorporated on 13 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Baysil Pharma has 1 deal on record (1 secondary share transfer); the latest was in September 2012.
Nalini Hiren Vashi ceased to be Director on 08 Nov 2018. Manasvvi Naishadh Desai ceased to be Additional Director on 28 Sep 2018. Manasvvi Naishadh Desai was appointed as Director on 09 Jan 2018. Baysil Pharma has 4 board changes on record in total.
Baysil Pharma can be reached through the website basilpharmaceutical.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Baysil Pharma is at F – 18 F Block Road MIDC Marol Andheri East, Mumbai, Maharashtra, India – 400093.
Baysil Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.